Sapphire Medical Clinics launches the UK’s first medical cannabis dermatology service for challenging skin conditions

11th September 2020
By Emily Ledger

Today, Sapphire Medical Clinics can offer treatment with medical cannabis to patients with rare and challenging skin conditions as the UK’s first dermatology service in this space.

As the first medical cannabis clinic to be registered with the Care Quality Commission (CQC), Sapphire leads the way in treating patients with cannabis-based medicines for all conditions where there is clinical evidence for efficacy. Patients with rare and difficult to treat skin conditions such as itching, or psoriasis are now able seek a second opinion regarding medicinal cannabis when conventional therapies have not achieved adequate benefit and symptom relief. Treatment for dermatological conditions may consist of either topical or systemic therapies.

Sapphire’s Medical Director, Dr Michael Platt, comments on today’s launch ‘We are very excited to partner with leading dermatologists to launch this service. We pride ourselves on individualised patient treatment delivered in a safe and effective way and rigorously monitored treatment outcomes’

Sapphire Consultant Dermatologist, Dr Anastasia Therianou, whose NHS practice is based at Imperial College Healthcare NHS Trust commented ‘I am delighted to join Sapphire Medical Clinics and now safely offer patients the additional option of cannabis-based medicines when they have not received symptom relief from routinely available therapies. The Sapphire Real-World Evidence platform allows us to support the growing clinical practice with robust data collection, which is of vital importance to the clinical community and patients’

Sapphire Consultant Dermatologist Dr Richard Watchorn, also based at Imperial College Healthcare NHS Trust for his NHS practice added ‘I look forward to setting up this service to serve unmet patient needs and in doing so, to contribute to the growing evidence base of cannabis-based medicines in dermatology’

On today’s announcement that Sapphire is launching the UK’s first medical cannabis dermatology service, 46 year old patient Shane Pearce commented “I am pleased that patients who suffer from hard to treat skin problems such as mine now have an additional option in medical cannabis when standard therapies have not been effective. I have tried numerous natural balms and creams, but nothing worked so I welcome the opportunity to consider this treatment option at Sapphire Medical Clinics”

Read more about conditions and medical cannabis here. To find out if you are eligible for treatment with medical cannabis, please get in touch via our Eligibility Assessment option.

Product Scores

No scores for this product.


No comments for this product.

Related Stories

Did you know Medical Cannabis was legal in the UK?
Would you like to know the results of our polls? Please complete the data request form by clicking here.

About the Author

Emily Ledger
Prior to joining the team at Canex, Emily studied Journalism at Sheffield Hallam University for three years. During her studies, she specialised in magazine and feature writing and went on to contribute to both the content and design departments at a local magazine. Emily is now the Head of Content at Canex where she has been both curating and contributing articles and content since the launch of the website.

Enjoying this article?

Join the thousands of subscribers who stay ahead of the game.

Advertise on Canex

Reach thousands of customers, as well as industry leaders and manufacturers
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on reddit
Share on whatsapp

Subscribe to our newsletter

All the latest CBD news & updates, direct to your inbox
By submitting this form, you are giving Canex permission to contact you directly via email or telephone. You can opt out at any stage, and your contact data will never be shared with any 3rd party without your explicit consent. Our Privacy Policy.

Keeping subscribers up-to-date with news & insight within the CBD industry. From regulation and legislation reforms, industry updates and guides through the ongoing studies of the substance; to product news, reviews and guides.

© 2020 | Canex Group Ltd | All Rights Are Reserved